These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 7435882)
21. Tachibana trait: human high molecular weight kininogen deficiency with diminished levels of prekallikrein and low molecular weight kininogen. Nakamura K; Iijima K; Fukuda C; Kadowaki H; Ikoma H; Oh-ishi S; Uchida Y; Katori M Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1473-9. PubMed ID: 3853954 [No Abstract] [Full Text] [Related]
22. Factors affecting the rate of contact activation in human plasma. Brunnée T; Coy G; Reddigari SR; Silverberg M Agents Actions Suppl; 1992; 38 ( Pt 2)():231-6. PubMed ID: 1462830 [TBL] [Abstract][Full Text] [Related]
23. Reduction of contact factors in sickle cell disease. Gordon EM; Klein BL; Berman BW; Strandjord SE; Simon JE; Coccia PF J Pediatr; 1985 Mar; 106(3):427-30. PubMed ID: 3844465 [TBL] [Abstract][Full Text] [Related]
24. Studies on the contact system of coagulation during therapy with high doses of recombinant IL-2: implications for septic shock. Hack CE; Wagstaff J; Strack van Schijndel RJ; Eerenberg AJ; Pinedo HM; Thijs LG; Nuijens JH Thromb Haemost; 1991 May; 65(5):497-503. PubMed ID: 1871710 [TBL] [Abstract][Full Text] [Related]
25. Initiation of contact activation by sulfatides. Tans G; Griffin JH Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464 [TBL] [Abstract][Full Text] [Related]
26. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. Weiss AS; Gallin JI; Kaplan AP J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577 [TBL] [Abstract][Full Text] [Related]
27. Prekallikrein deficiency in a family of miniature horses. Turrentine MA; Sculley PW; Green EM; Johnson GS Am J Vet Res; 1986 Nov; 47(11):2464-7. PubMed ID: 3641551 [TBL] [Abstract][Full Text] [Related]
28. Association of factor XI and high molecular weight kininogen in human plasma. Thompson RE; Mandle R; Kaplan AP J Clin Invest; 1977 Dec; 60(6):1376-80. PubMed ID: 915004 [TBL] [Abstract][Full Text] [Related]
29. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens. Imamura T; Dubin A; Moore W; Tanaka R; Travis J Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782 [TBL] [Abstract][Full Text] [Related]
30. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases. España F; Ratnoff OD J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536 [TBL] [Abstract][Full Text] [Related]
31. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Mandle RJ; Colman RW; Kaplan AP Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308 [TBL] [Abstract][Full Text] [Related]
32. Reduced titers of Hageman factor (factor XII) in Orientals. Gordon EM; Donaldson VH; Saito H; Su E; Ratnoff OD Ann Intern Med; 1981 Dec; 95(6):697-700. PubMed ID: 7305148 [TBL] [Abstract][Full Text] [Related]
33. Studies of components of the coagulation systems in normal individuals and septic shock patients. Smith-Erichsen N; Aasen AO; Gallimore MJ; Amundsen E Circ Shock; 1982; 9(5):491-7. PubMed ID: 7172424 [TBL] [Abstract][Full Text] [Related]
35. Abnormalities in the contact activation through factor XII in Fujiwara trait: a deficiency in both high and low molecular weight kininogens with low level of prekallikrein. Oh-ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I Tohoku J Exp Med; 1981 Jan; 133(1):67-80. PubMed ID: 6785899 [TBL] [Abstract][Full Text] [Related]
36. Participation of Hageman factor dependent pathways in human disease states. Colman RW; Wong PY Thromb Haemost; 1977 Dec; 38(4):751-75. PubMed ID: 341410 [TBL] [Abstract][Full Text] [Related]
37. Molecular assembly in the contact phase of the Hageman factor system. Cochrane CG; Griffin JH Am J Med; 1979 Oct; 67(4):657-64. PubMed ID: 386794 [TBL] [Abstract][Full Text] [Related]
38. Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma. Johne J; Blume C; Benz PM; Pozgajová M; Ullrich M; Schuh K; Nieswandt B; Walter U; Renné T Biol Chem; 2006 Feb; 387(2):173-8. PubMed ID: 16497149 [TBL] [Abstract][Full Text] [Related]
39. [Use of chromogenic substrates in the clarification of disorders in the early stages of blood coagulation]. Vogel G; Stürzebecher J; Klessen C; Lauten G Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):115-20. PubMed ID: 6177592 [TBL] [Abstract][Full Text] [Related]
40. The mRNAs of prekallikrein, factors XI and XII, and kininogen, components of the contact phase cascade are differentially expressed in multiple non-hepatic human tissues. Neth P; Arnhold M; Nitschko H; Fink E Thromb Haemost; 2001 Jun; 85(6):1043-7. PubMed ID: 11434682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]